tm
Seeing Is Believing
tm
Seeing Is Believing
IMPL is currently covered by 1 analysts with an average price target of $1.98. This is a potential upside of $1.96 (9800%) from yesterday's end of day stock price of $0.02.
Impel Neuropharma's activity chart (see below) currently has 3 price targets and 3 ratings on display. The stock rating distribution of IMPL is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 80 days.
Highest price target for IMPL is $3, Lowest price target is $3, average price target is $1.98.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 15-Nov-2022. First documented stock forecast 18-May-2021.
Currently out of the existing stock ratings of IMPL, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5
$4.98 (24900.00%)
31
1 years 5 months 18 days ago
1/3 (33.33%)
$1.96 (64.47%)
80
What is IMPL (Impel Neuropharma) average time for price targets to be met?
Which analyst has the current highest performing score on IMPL (Impel Neuropharma) with a proven track record?
Which analyst has the most public recommendations on IMPL (Impel Neuropharma)?
Which analyst is the currently most bullish on IMPL (Impel Neuropharma)?
